[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  d_stock [@d_stock07734](/creator/twitter/d_stock07734) on x XXX followers Created: 2025-07-26 20:26:46 UTC Forget about the prediction $NWBO will be a trillion-dollar company. Merck only made less than $1b from Prenvar13 vaccine. Merck will be the first trillion-dollar BP once keytruda, Prenvar13, and TLR4 are combined with the DC vaccine therapy. Dendritic Cell Therapy With Pembrolizumab for Metastatic or Unresectable Melanoma Study Start (Actual): 2017-11-15 Primary Completion (Actual): 2020-06-14 Principal Investigator:Matthew S. Block, M.D., Ph.D.,Mayo Clinic Phase Ib/II Study of Autologous Dendritic Cell Therapy Delivered Intratumorally After Cryoablation in Combination With Pembrolizumab for Patients With Metastatic or Unresectable Melanoma Vaccine Therapy With or Without Cryosurgery in Treating Patients With Residual, Relapsed, or Refractory B-Cell Non-Hodgkin Lymphoma Study Start (Actual): 2010-11 Primary Completion (Actual): 2015-11-24 Study Chair: Yi Lin, M.D.,Mayo Clinic Dendritic cell vaccine treatment for indolent B cell non-hodgkin lymphoma: clinical trial in progress Dendritic Cell Therapy, Cryosurgery, and Pembrolizumab in Treating Patients With Non-Hodgkin Lymphoma Phase I/II Study of Dendritic Cell Therapy Delivered Intratumorally After Cryoablation and Anti-PD-1 Antibody (Pembrolizumab) for Patients With Non-Hodgkin Lymphoma Study Start (Actual):2017-08-15 Primary Completion (Actual): 2022-01-25 Principal Investigator:Yi Lin, MD, PhD,Mayo Clinic 2022 2020 2019 2018  XXXXX engagements  **Related Topics** [os](/topic/os) [$1b](/topic/$1b) [$nwbo](/topic/$nwbo) [$mrk](/topic/$mrk) [stocks healthcare](/topic/stocks-healthcare) [Post Link](https://x.com/d_stock07734/status/1949204769085820958)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
d_stock @d_stock07734 on x XXX followers
Created: 2025-07-26 20:26:46 UTC
Forget about the prediction $NWBO will be a trillion-dollar company. Merck only made less than $1b from Prenvar13 vaccine. Merck will be the first trillion-dollar BP once keytruda, Prenvar13, and TLR4 are combined with the DC vaccine therapy.
Dendritic Cell Therapy With Pembrolizumab for Metastatic or Unresectable Melanoma
Study Start (Actual): 2017-11-15 Primary Completion (Actual): 2020-06-14
Principal Investigator:Matthew S. Block, M.D., Ph.D.,Mayo Clinic
Phase Ib/II Study of Autologous Dendritic Cell Therapy Delivered Intratumorally After Cryoablation in Combination With Pembrolizumab for Patients With Metastatic or Unresectable Melanoma
Vaccine Therapy With or Without Cryosurgery in Treating Patients With Residual, Relapsed, or Refractory B-Cell Non-Hodgkin Lymphoma
Study Start (Actual): 2010-11 Primary Completion (Actual): 2015-11-24 Study Chair: Yi Lin, M.D.,Mayo Clinic
Dendritic cell vaccine treatment for indolent B cell non-hodgkin lymphoma: clinical trial in progress
Dendritic Cell Therapy, Cryosurgery, and Pembrolizumab in Treating Patients With Non-Hodgkin Lymphoma Phase I/II Study of Dendritic Cell Therapy Delivered Intratumorally After Cryoablation and Anti-PD-1 Antibody (Pembrolizumab) for Patients With Non-Hodgkin Lymphoma
Study Start (Actual):2017-08-15 Primary Completion (Actual): 2022-01-25 Principal Investigator:Yi Lin, MD, PhD,Mayo Clinic
2022
2020
2019
2018
XXXXX engagements
Related Topics os $1b $nwbo $mrk stocks healthcare